If you were a manufacturer of one of the drugs, would you voluntarily disclose the study information?
Stanford University medical researchers conducted a study on
the correlation between the use of fertility drugs and ovarian cancer.
Their study, published in the American Journal of Epidemiology,
concludes that the use of the fertility drugs, Pergonal and Serophene,
may increase the risk of ovarian cancer by three times. The lead author
of the studies, Professor Alice Whittemore, stated, “Our finding in
regard to fertility drugs is by no means certain. It is based on very
small numbers and is really very tenuous.”
FDA Commissioner David Kessler would like the infertility drug
manufacturers to disclose the study findings and offer a warning on the
drug packages. He notes, “Even though the epidemiology study is still
preliminary, women have a right to know what is known. We’re not looking
to make more of this than there is.”
If you were a manufacturer of one of the drugs, would you voluntarily disclose the study information?
